Holen Sie sich die Stockscreener-App
4.87
3.84%
0.18
Finanzdaten der Cellectar Biosciences Inc-Aktie (CLRB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Research and Development |
30.27%
2.3898
|
3.4271 | 6.2092 | 5.4935 | 7.3455 |
| Costs And Expenses |
5.68%
6.0375
|
6.401 | 12.74 | 13.33 | 13.70 |
| Operating Income/Loss |
5.68%
-6.0375
|
-6.401 | -12.74 | -13.33 | -13.70 |
| Nonoperating Income/Loss |
390.40%
0.5896
|
-0.203 | 10.46 | -1.337 | 12.78 |
| Income/Loss From Continuing Operations Before Tax |
8.58%
-6.0375
|
-6.604 | -5.4826 | -13.33 | -0.9194 |
| Income/Loss From Continuing Operations After Tax |
17.51%
-5.4479
|
-6.604 | -2.3554 | -14.66 | -0.9194 |
Net Income/Loss
|
17.51%
-5.4479
|
-6.604 | -2.3554 | -14.66 | -0.9194 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
96.51%
1.6088
|
46.08 | 1.772 | 39.34 | 35.82 |
| Diluted Average Shares |
96.51%
1.6088
|
46.08 | 1.5983 | 39.79 | 37.45 |
| Basic Earnings Per Share |
2,321%
-3.39
|
-0.14 | -0.01 | -0.37 | -0.03 |
| Diluted Earnings Per Share |
2,321%
-3.39
|
-0.14 | -0.01 | -0.40 | -0.18 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.96%
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):